Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

KODIAK SCIENCES INC.

(KOD)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur KODIAK SCIENCES INC.
10/01KODIAK SCIENCES : Corporate Presentation (dated January 2022)
03/01Kodiak Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021INSIDER SELL : Kodiak Sciences
2021Kodiak Sciences Completes Enrollment for Phase 3 Trial of Eye Disease Drug Candidate KS..
2021Kodiak Sciences Completes Enrollment in BEACON Phase 3 Clinical Trial of KSI-301 in Pat..
2021Kodiak Sciences Inc. Completes Enrollment in BEACON Phase 3 Clinical Trial of KSI-301 i..
2021INSIDER SELL : Kodiak Sciences
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
2021KODIAK SCIENCES INC. Management's Discussion and Analysis of Financial Condition and R..
2021Kodiak Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months End..
2021Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent Business High..
2021Earnings Flash (KOD) KODIAK SCIENCES Reports Q3 Loss $-1.30
2021Kodiak Sciences Announces Third Quarter 2021 Financial Results and Recent Business High..
2021Kodiak Sciences to Present at Upcoming Conferences
2021Health Care Stocks Largely Sputter in Monday Trading
2021Health Care Stocks Higher in Monday Trading Amid Large Gains by Biotechs
2021INSIDER SELL : Kodiak Sciences
2021KODIAK SCIENCES : Summary of the LTPIP - Form 8-K
2021KODIAK SCIENCES INC. : Change in Directors or Principal Officers, Submission of Matters to..
2021INSIDER SELL : Kodiak Sciences
2021PAY FOR PERFORMANCE : Program Aligns Incentives to Significant Value Creation through Shar..
2021KODIAK SCIENCES INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2021KODIAK SCIENCES : Announces New Long-Term Performance Incentive Plan
2021KODIAK SCIENCES : to Present at the Morgan Stanley 19th Annual Global Healthcare Conferenc..
2021NORTH AMERICAN MORNING BRIEFING : Weak Chinese -3-
2021KODIAK SCIENCES : Corporate Presentation (dated August 2021)
2021KODIAK SCIENCES : Management's Discussion and Analysis of Financial Condition and Results ..
2021Kodiak Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 202..
2021KODIAK SCIENCES : Announces Second Quarter 2021 Financial Results and Recent Business High..
2021KODIAK SCIENCES : Earnings Flash (KOD) KODIAK SCIENCES Posts Q2 Loss $-1.08
2021KODIAK SCIENCES : Letter Agreement, dated July 22, 2021 (Form 8-K)
2021KODIAK SCIENCES INC. : Entry into a Material Definitive Agreement, Financial Statements an..
2021KODIAK SCIENCES INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
2021KODIAK SCIENCES : to Present at Upcoming Conferences
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors Kodiak S..
2021KODIAK SCIENCES : Corporate Presentation (dated May 2021)
2021KODIAK SCIENCES : Announces First Quarter 2021 Financial Results and Recent Business Highl..
2021SECTOR UPDATE : Health Care Stocks Ending Tuesday Session Lower, But Biotech Shares Rise
2021SECTOR UPDATE : Health Care Stocks Drifting Lower in Tuesday Trading
2021KODIAK SCIENCES : Files Shelf For Up to 14 Million Common Shares on Behalf of Selling Stoc..
2021KODIAK SCIENCES : Management's Discussion and Analysis of Financial Condition and Results ..
2021KODIAK SCIENCES : Earnings Flash (KOD) KODIAK SCIENCES Posts Q1 Loss $-0.98
2021KODIAK SCIENCES : Q1 Loss Widens
2021Wall Street Sees Cautiously Mixed Open, Oil Prices Surge After Pipeline Cyber-Attack
2021KODIAK SCIENCES : Announces First Quarter 2021 Financial Results and Recent Business Highl..
2021KODIAK SCIENCES : to Present at Upcoming Conferences
2021KODIAK SCIENCES : to Present at Upcoming Conferences
2021KODIAK SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
2021KODIAK SCIENCES : Q4 Loss Widens
2021KODIAK SCIENCES : Announces Fourth Quarter and Full Year 2020 Financial Results and Recent..
2021Kodiak Sciences Inc. Reports Earnings Results for the Fourth Quarter Ended December 31,..
2021SECTOR UPDATE : Health Care Stocks Firming Just Ahead of Wednesday Close
2021SECTOR UPDATE : Health Care Stocks Nudging Higher on Wednesday
2021KODIAK SCIENCES : Corporate Presentation February 2021
2021KODIAK SCIENCES : Announces 1-Year Durability, Efficacy and Safety Data from Ongoing Phase..
2021Kodiak Sciences Inc. Announces 1-Year Durability, Efficacy and Safety Data from Ongoing..
2021KODIAK SCIENCES : Announces Upcoming Presentation of KSI-301 Phase 1b Clinical Study Data ..
2021Certain Restricted Stock Awards of Kodiak Sciences Inc. are subject to a Lock-Up Agreem..
2021Certain Options of Kodiak Sciences Inc. are subject to a Lock-Up Agreement Ending on 17..
2021Certain Warrants of Kodiak Sciences Inc. are subject to a Lock-Up Agreement Ending on 1..
2021Certain Common Stock of Kodiak Sciences Inc. are subject to a Lock-Up Agreement Ending ..
2021KODIAK SCIENCES : to Present at the J.P. Morgan Healthcare Conference
2020KODIAK SCIENCES : Raises $645 Million in Public Offering
2020KODIAK SCIENCES : Announces Closing of $645.0 Million Public Offering of Common Stock and ..
2020CLOSE UPDATE : Stocks End Lower as Rising COVID-19 Cases Offset Vaccine Optimism
2020KODIAK SCIENCES INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2020UPDATE : Kodiak Sciences Prices $560.9 Million Public Share Offering; Shares Up 21% Wednes..
2020MIDDAY REPORT : Wall Street Edges Higher on Vaccine Breakthrough
2020KODIAK SCIENCES : Prices $560.9 Million Public Share Offering
2020KODIAK SCIENCES : Announces Pricing of $560.9 Million Public Offering of Common Stock
2020KODIAK SCIENCES : Kicks Off $400 Million Common Stock Offering; Shares Down After-Hours
2020KODIAK SCIENCES : Announces Proposed Offering of Common Stock
2020KODIAK SCIENCES : Completes Enrollment of Phase 2b/3 Study of KSI-301 as Potential Retinal..
2020Kodiak Sciences Completes Enrollment of DAZZLE Phase 2b/3 Pivotal Study of KSI-301 in P..
2020MIDDAY REPORT : Wall Street Firmer After Choppy Trading Week
1  2  3Suiv.
Prochain événement sur KODIAK SCIENCES INC.